Atrial Fibrillation in Patients With Cancer: A Persistent and Increasing Challenge
- PMID: 37144117
- PMCID: PMC10152204
- DOI: 10.1016/j.jaccao.2023.03.007
Atrial Fibrillation in Patients With Cancer: A Persistent and Increasing Challenge
Keywords: arrhythmia; atrial fibrillation; cardio-oncology; cardiotoxicity; onco-cardiology; oncotherapeutics; pharmacovigilance; risk models.
Conflict of interest statement
Dr Ellinor is supported by grants from the National Institutes of Health (1RO1HL092577, 1R01HL157635, and 5R01HL139731), the American Heart Association Strategically Focused Research Networks (18SFRN34110082), and the European Union (MAESTRIA 965286); has received sponsored research support from Bayer, IBM Research, Bristol Myers Squibb, and Pfizer; and has served on advisory boards or consulted for Bayer, MyoKardia, and Novartis. Dr Suero-Abreu has reported that she has no relationships relevant to the contents of this paper to disclose.
Comment on
- doi: 10.1016/j.jaccao.2022.11.019
References
Publication types
LinkOut - more resources
Full Text Sources
